" class="no-js "lang="en-US"> Rocket VR Health - Medtech Alert
Wednesday, October 02, 2024

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Rocket VR Health | Pharmtech Focus

Rocket VR Health

About Rocket VR Health

Rocket VR Health

Rocket VR Health is developing virtual reality digital therapeutics to address unmet mental health needs in cancer patients and survivors. Our digital interventions take clinically validated treatments and transform them into on-demand VR programs that make psychosocial care for cancer more effective, accessible, and data-driven.

Related Story

Artificial Intelligence

 Rocket VR Health Partners with Penn Medicine's Abramson Cancer Center to Study the Use of VR in Patients Undergoing Radiation Therapy | Pharmtech Focus

Rocket VR Health Partners with Penn Medicine's Abramson Cancer Center to Study the Use of VR in Patients Undergoing Radiation Therapy

August 19 2022

Rocket VR Health, a digital therapeutics company developing immersive therapy programs, is partnering with Penn Medicine’s […]